investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Nathanael S Gray
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Nathanael S Gray
Dana-Farber Cancer Institute
Boston, United States
Subrahmanyam Vangala
Sai Advantium Pharma Ltd.
Pune, India
Related projects
Pier Paolo Pandolfi
PTEN in ontogenesis and tumor suppression
Breast
Tim Greten
Analysis of Cancer-Related Immune Suppressor Mechanisms in Mice
Breast
Mikhail Nikiforov
KLF9-TXNRD2 axis in melanoma progression and metastasis
Melanoma of skin
William C Hahn
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
Melanoma of skin
Anatoly Zhitkovich
Genotoxicity of Chromium Compounds
Melanoma of skin
Matthew Bogyo
Chemical Probes for Specific Targeting of Matrix Metallo Proteases
Breast
Steven E Artandi
Telomeres, Telomerase and Tumor Progression
Melanoma of skin
Wu-Min Deng
Intercellular Communication and Oocyte Polarity
Melanoma of skin
Pathology
Maria Jasin
HOMOLOGY-DIRECTED DNA REPAIR PROTEINS BRCA2 AND RAD51 IN TUMOR RELEVANT TISSUES
Breast